Cocaine Use Disorder
3
Pipeline Programs
2
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Soterix MedicalNJ - Woodbridge
3 programs1
transcranial direct current stimulatorPhase 21 trial
Soterix Medical mini-CT tDCS stimulatorN/A1 trial
Transcranial Direct Current StimulatorN/A1 trial
Active Trials
Tempero BioCA - Oakland
2 programs2
Cohort 1 - TMP-301Phase 11 trial
TMP-301Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Soterix Medicaltranscranial direct current stimulator
Tempero BioTMP-301
Tempero BioCohort 1 - TMP-301
Soterix MedicalTranscranial Direct Current Stimulator
Soterix MedicalSoterix Medical mini-CT tDCS stimulator
Clinical Trials (5)
Total enrollment: 48 patients across 5 trials
TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
Start: Sep 2020Est. completion: Sep 2022
Phase 2Completed
A Study to Investigate the Interaction Between TMP-301 and Cocaine.
Start: Jan 2025Est. completion: May 202518 patients
Phase 1Completed
Multiple Ascending Dose Study of TMP-301 in Healthy Subjects
Start: Jan 2023Est. completion: Jan 202430 patients
Phase 1Completed
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
Start: Feb 2026Est. completion: Feb 2030
N/ARecruiting
TDCS for Cocaine Addiction Craving
Start: Feb 2019Est. completion: Sep 2019
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 48 patients
2 companies competing in this space